PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancer
Phase 1
- Conditions
- Advanced or recurrent gastric cancer refractory to standard therapeutic modality
- Registration Number
- JPRN-UMIN000004389
- Lead Sponsor
- Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy Uncontrolled infection Patients with serious concomitant disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Overall survival
- Secondary Outcome Measures
Name Time Method Time to treatment failure Progression free survival Antitumor immune responses